CCEL
CryoCell International Inc
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.7% | 42.5% | -4.5% | 22.1% | 30.2% | 26.9% | 12.0% | 8.9% | 32.4% | 16.3% | 8.5% | 23.7% | 20.3% | |
| 5.3% | 5.2% | 2.1% | 2.3% | 4.1% | 4.2% | 4.3% | 4.3% | 4.5% | 4.2% | 4.5% | 4.4% | 4.4% | |
| 2.2% | 2.2% | 3.9% | 2.2% | 1.8% | 1.9% | 3.7% | 0.5% | 0.5% | 0.5% | 2.1% | 0.8% | 1.0% | |
| 3.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.7% | 57.5% | -18.4% | 7.2% | 13.2% | 43.7% | -3.4% | -7.1% | 10.0% | 36.8% | -4.6% | 8.1% | 12.7% | |
| 43.5% | 21.8% | 5.8% | 33.4% | 4.0% | 1.8% | 0.8% | 0.8% | 0.5% | 0.9% | 0.9% | 0.4% | 0.7% | |
| -43.0% | -25.2% | -4.3% | -34.2% | -8.3% | -13.9% | -3.6% | -19.0% | 14.1% | -3.7% | 0.2% | 0.5% | 2.8% | |
| – | – | 0.0% | 0.0% | – | – | 25.4% | 15.3% | – | 0.0% | 0.0% | 0.0% | – | |
| -0.1% | 10.1% | -2.2% | -15.4% | -0.2% | 0.0% | 0.0% | -1.1% | -1.0% | 0.0% | – | – | – | |
| 11.6% | – | – | 27.5% | -25.1% | 15.8% | 12.8% | 25.3% | – | -12.0% | -9.6% | -21.2% | – | |
| 11.5% | -19.6% | 6.9% | 15.0% | -25.3% | -8.4% | -12.6% | 9.0% | -44.9% | -12.0% | -9.6% | -20.9% | -21.9% | |
| -6.9% | -2.3% | -2.0% | 2.8% | -3.4% | 4.5% | -4.2% | -1.1% | 1.6% | 0.7% | -0.9% | 3.3% | 1.2% | |
| -18.8% | 20.7% | -10.4% | -11.3% | 26.3% | 25.1% | 11.2% | 8.1% | 31.9% | 15.5% | 7.6% | 23.3% | 19.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.